Table 2 Distribution of C-reactive protein and CSF laboratory findings and Evaluation of imaging results.
From: Multicenter prospective surveillance study of viral agents causing meningoencephalitis
Enterovirus (n = 12) | Adenovirus (n = 11) | HHV type6 (n = 11) | HHV type7 (n = 5) | EBV (n = 3) | HSV type 1 (n = 3) | CMV (n = 3) | Negative (n = 136) | |
|---|---|---|---|---|---|---|---|---|
C reactive protein positivity | 83.3% (n = 10) | 54.5% (n = 6) | 45.5% (n = 5) | 80% (n = 4) | 66.6% (n = 2) | 33.3% (n = 1) | 33.3% (n = 1) | 55.8% (n = 76) |
Anormal BOS WBC count | 83.3% (n = 10) | 27.2% (n = 3) | 18.1% (n = 2) | 80% (n = 4) | 66.6% (n = 2) | 0% (n = 0) | 66.6% (n = 2) | 27.2% (n = 37) |
Iıncreased CSF protein by age | 33.3% (n = 4) | 27.2% (n = 3) | 36.3% (n = 4) | 60% (n = 3) | 66.6% (n = 2) | 66.6% (n = 2) | 0% (n = 0) | 26.4% (n = 36) |
Imagining | ||||||||
CT | 2 | 3 | 6 | 1 | 1 | 0 | 3 | 68 |
Normal | 2 | 3 | 6 | 1 | 1 | 0 | 3 | 68 |
Anormal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MRI | 8 | 7 | 6 | 4 | 2 | 3 | 2 | 66 |
Normal | 7 | 6 | 6 | 2 | 0 | 2 | 2 | 61 |
Anormal | 1 | 1 | 0 | 2 | 2 | 1 | 0 | 5 |
Transfontanel USG | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
Normal | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
Anormal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EEG | 1 | 3 | 1 | 0 | 0 | 1 | 2 | 20 |
Normal | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 6 |
Anormal | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 14 |
